Zhu Cuiling, Zhang Yi, Wang Xingchun, Gao Jingyang, Lu Liesheng, Zhou Donglei, Qu Shen
Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Department of Gastrointestinal surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):405-410.
To investigate the effect of laparoscopic sleeve gastrectomy(LSG) on sex hormone in male patients with severe obesity.
Retrospective analysis was performed in 31 male patient with severe obese [body mass index(BMI) ≥28 kg/m, obesity group] who underwent LSG in Shanghai Tenth People's Hospital of Tongji University from December 2012 to May 2016. The anthropometric parameters(weight, BMI, waist circumference, hip circumference, waist-hip ratio, body fat percentage), glucose metabolic indices [fasting plasma glucose(FPG), fasting insulin (FINS), glycosylated hemoglobin (HbA1c), homeostasis model assessment-insulin resistance index(HOMA-IR)], and sex hormone parameters [estradiol(E2), total testosterone (TT), follicle-stimulating hormone (FSH) and luteinizing hormone (LH)] were collected preoperatively and 1, 3, 6 months postoperatively. In addition, 31 healthy male volunteers with normal BMI were consecutively recruited in this study as control group. The above-mentioned parameters were also determined in control group. Changes of these variables before and after surgery were analyzed. Pearson method was used to analyze the correlation of TT with anthropometric parameters and glucose metabolic indices before and after surgery.
The average age of patients in obesity and control group was (32.9±9.7) (18 to 56) years and (30.7±8.9) (18 to 49) years. Compared to the control group, obesity group had significantly higher anthropometric parameters and glucose metabolic indices before surgery (all P<0.05). In obesity group, the anthropometric and glucose metabolic indices significantly decreased at 1 to 6 months after surgery compared to those before surgery (all P<0.05). At 1 month after surgery, the anthropometric parameters and glucose metabolic indices in obesity group were significantly higher than those in control group (all P<0.05). At 3, and 6 months after surgery, there were no significant differences in glucose metabolic indices between obesity and control group (all P>0.05), while the anthropometric parameters in obesity group were still significantly higher than those in control group(all P<0.05). The sex hormone parameters in control and obesity group before surgery were as follows: E2: (100.2±23.5) pmol/L and (129.2±81.9) pmol/L; TT: (18.0±4.9) nmol/L and (8.4±4.5) nmol/L; FSH: (4.5±3.1) IU/L and (4.3±2.5) IU/L; LH: (4.4±1.7) IU/L and (5.3±2.6) IU/L. Compared to control group, the TT level of obese patients before surgery significantly decreased(P=0.000), while no significant differences were observed in the levels of E2, FSH, and LH(all P>0.05). The TT levels were significantly increased at 1, 3, 6 months after surgery[(13.1±7.0), (13.6±5.7), (21.0±19.3) nmol/L, respectively, all P<0.05] and the E2 level was significantly decreased at 6 months after surgery [(91.4±44.9) pmol/L, P<0.05], while no significant differences were observed at 1 and 3 months after surgery (all P>0.05). Furthermore, the FSH and LH levels did not exhibit significant change at 1, 3, and 6 months after surgery compared to those before surgery (all P>0.05). At 1 month after surgery, no significant correlations were examined in the change value of TT levels (▹TT) with the changes of BMI(▹BMI), FPG(▹FPG), FINS(▹FINS), HOMA-IR(▹HOMA-IR), and E2(▹E2) (all P>0.05). At 3 months after surgery, ▹TT was negatively correlated with ▹BMI (r=-0.441, P=0.015), ▹FINS (r=-0.375, P=0.041), and ▹HOMA-IR(r=-0.397, P=0.030), but not correlated with ▹FPG and ▹E2 (all P>0.05). At 6 months after surgery, ▹TT was negatively correlated with ▹BMI(r=-0.510, P=0.018) and ▹HOMA-IR (r=-0.435, P=0.049), but not correlated with ▹FPG, ▹FINS and ▹E2 (all P>0.05).
Male severe obese patients are accompanied with abnormal sex hormone levels. LSG has a significant effect on weight loss and blood glucose improvement, and may ameliorate the sex hormone unbalance by improving the insulin resistance in men with severe obesity.
探讨腹腔镜袖状胃切除术(LSG)对重度肥胖男性患者性激素的影响。
回顾性分析2012年12月至2016年5月在同济大学附属上海市第十人民医院接受LSG的31例重度肥胖男性患者[体重指数(BMI)≥28 kg/m²,肥胖组]。收集术前及术后1、3、6个月的人体测量参数(体重、BMI、腰围、臀围、腰臀比、体脂百分比)、糖代谢指标[空腹血糖(FPG)、空腹胰岛素(FINS)、糖化血红蛋白(HbA1c)、稳态模型评估胰岛素抵抗指数(HOMA-IR)]和性激素参数[雌二醇(E2)、总睾酮(TT)、促卵泡生成素(FSH)和黄体生成素(LH)]。此外,连续招募31例BMI正常的健康男性志愿者作为对照组。对照组也测定上述参数。分析手术前后这些变量的变化。采用Pearson法分析手术前后TT与人体测量参数和糖代谢指标的相关性。
肥胖组和对照组患者的平均年龄分别为(32.9±9.7)(18至56)岁和(30.7±8.9)(18至49)岁。与对照组相比,肥胖组术前人体测量参数和糖代谢指标显著更高(均P<0.05)。在肥胖组中,术后1至6个月人体测量和糖代谢指标与术前相比显著降低(均P<0.05)。术后1个月,肥胖组的人体测量参数和糖代谢指标显著高于对照组(均P<0.05)。术后3个月和6个月,肥胖组和对照组的糖代谢指标无显著差异(均P>0.05),而肥胖组的人体测量参数仍显著高于对照组(均P<0.05)。对照组和肥胖组术前的性激素参数如下:E2:(100.2±23.5)pmol/L和(129.2±81.9)pmol/L;TT:(18.0±4.9)nmol/L和(8.4±4.5)nmol/L;FSH:(4.5±3.1)IU/L和(4.3±2.5)IU/L;LH:(4.4±1.7)IU/L和(5.3±2.6)IU/L。与对照组相比,肥胖患者术前的TT水平显著降低(P=0.000),而E2、FSH和LH水平无显著差异(均P>0.05)。术后1、3、6个月TT水平显著升高[分别为(13.1±7.0)、(13.6±5.7)、(21.0±19.3)nmol/L,均P<0.05],术后6个月E2水平显著降低[(91.4±44.9)pmol/L,P<0.05],而术后1个月和3个月无显著差异(均P>0.05)。此外,术后1、3、6个月FSH和LH水平与术前相比无显著变化(均P>0.05)。术后1个月,TT水平变化值(△TT)与BMI变化值(△BMI)、FPG变化值(△FPG)、FINS变化值(△FINS)、HOMA-IR变化值(△HOMA-IR)和E2变化值(△E2)之间无显著相关性(均P>0.05)。术后3个月,△TT与△BMI(r=-0.441,P=0.015)、△FINS(r=-0.375,P=0.041)和△HOMA-IR(r=-0.397,P=0.030)呈负相关,但与△FPG和△E2无相关性(均P>0.05)。术后6个月,△TT与△BMI(r=-0.510,P=0.018)和△HOMA-IR(r=-0.435,P=0.049)呈负相关,但与△FPG、△FINS和△E2无相关性(均P>0.05)。
男性重度肥胖患者伴有性激素水平异常。LSG对体重减轻和血糖改善有显著作用,可能通过改善重度肥胖男性的胰岛素抵抗来改善性激素失衡。